Australia Markets closed

Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
20.84-0.41 (-1.93%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close21.25
Bid0.00 x 800
Ask0.00 x 800
Day's range21.08 - 21.28
52-week range17.19 - 30.14
Avg. volume722,061
Market cap2.243B
Beta (5Y monthly)0.55
PE ratio (TTM)24.52
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A

    5 big stock buybacks: Verisk, Con Edison | Pro Recap

    Here are 5 biggest share buyback announcements from the past week you may have missed on InvestingPro. Verisk Analytics (NASDAQ:VRSK) announced that it has entered into accelerated share repurchase agreements with each of Citibank, and Goldman Sachs to repurchase an aggregate of $2.5B of the company's common stock. Morgan Stanley said on Thursday it's adding a position to the company, given (1) industry-standard network effects in an attractive industry, (2) attractive valuation after the company’s return to its traditional property and casualty-focused end markets after selling non-core business segments, and (3) from a portfolio perspective, reduces the Model’s volatility and exposure to consumer discretionary while adding exposure to high-quality industrials.

  • Simply Wall St.

    Corcept Therapeutics Full Year 2022 Earnings: EPS Misses Expectations

    Corcept Therapeutics ( NASDAQ:CORT ) Full Year 2022 Results Key Financial Results Revenue: US$401.9m (up 9.8% from FY...

  • Zacks

    Corcept's (CORT) Q4 Earnings and Revenues Miss Estimates

    Corcept Therapeutics' (CORT) fourth-quarter earnings and revenues lag estimates.